• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炭疽芽孢杆菌20 kDa保护性抗原成分的活性

Activity of the Bacillus anthracis 20 kDa protective antigen component.

作者信息

Hammamieh Rasha, Ribot Wilson J, Abshire Terry G, Jett Marti, Ezzell John

机构信息

Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.

出版信息

BMC Infect Dis. 2008 Sep 22;8:124. doi: 10.1186/1471-2334-8-124.

DOI:10.1186/1471-2334-8-124
PMID:18808698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2564935/
Abstract

BACKGROUND

Anthrax is caused by Bacillus anthracis that produce two exotoxins, lethal toxin and edema toxin. The lethal toxin is composed of the lethal factor (LF) complexed with the cell binding protective antigen (PA83, 83 kDa). Likewise, the edema factor (EF) binds to the PA83 to form the edema toxin. Once PA83 is bound to the host cell surface, a furin-like protease cleaves the full-length, inactive protein into 63 kDa and 20 kDa antigens (PA63 and PA20). PA63 forms a heptamer and is internalized via receptor mediated endocytosis forming a protease-stable pore, which allows EF and LF to enter the cell and exert their toxic effects.Both proteolytically cleaved protective antigens (PA63 and PA20 fragments) are found in the blood of infected animals. The 63 kDa protective antigen PA63 fragment has been thoroughly studied while little is known about the PA20.

METHODS

In this study we examined the role of PA20 using high throughput gene expression analysis of human peripheral blood mononuclear cells (PBMC) exposed to the PA20. We constructed a PA mutant in which a Factor Xa proteolytic recognition site was genetically engineered into the protective antigen PA83 to obtain PA20 using limited digestion of this recombinant PA83 with trypsin.

RESULTS

Global gene expression response studies indicated modulation of various immune functions and showed gene patterns indicative of apoptosis via the Fas pathway in a subset of the lymphoid cells. This finding was extended to include observations of increased Caspase-3 enzymatic activity and the identification of increases in the population of apoptotic, but not necrotic cells, based on differential staining methods. We identified a list of approximately 40 inflammatory mediators and heat-shock proteins that were altered similarly upon exposure of PBMC to either rPA20 or B. anthracis spores/vegetative cells.

CONCLUSION

This study shows that the PA20 has an effect on human peripheral blood leukocytes and can induce apoptosis in the absence of other PA components.

摘要

背景

炭疽由炭疽杆菌引起,该菌可产生两种外毒素,即致死毒素和水肿毒素。致死毒素由与细胞结合保护性抗原(PA83,83 kDa)复合的致死因子(LF)组成。同样,水肿因子(EF)与PA83结合形成水肿毒素。一旦PA83与宿主细胞表面结合,一种类弗林蛋白酶将全长无活性蛋白切割成63 kDa和20 kDa抗原(PA63和PA20)。PA63形成七聚体,并通过受体介导的内吞作用内化,形成蛋白酶稳定的孔道,使EF和LF能够进入细胞并发挥其毒性作用。在受感染动物的血液中均发现了经蛋白水解切割的保护性抗原(PA63和PA20片段)。63 kDa保护性抗原PA63片段已得到充分研究,而关于PA20的了解却很少。

方法

在本研究中,我们通过对暴露于PA20的人外周血单个核细胞(PBMC)进行高通量基因表达分析,研究了PA20的作用。我们构建了一个PA突变体,其中在保护性抗原PA83中通过基因工程引入了一个凝血因子Xa蛋白水解识别位点,通过用胰蛋白酶对该重组PA83进行有限消化来获得PA20。

结果

整体基因表达反应研究表明,多种免疫功能受到调节,并显示出在一部分淋巴细胞中通过Fas途径指示细胞凋亡的基因模式。这一发现进一步扩展,包括观察到半胱天冬酶-3酶活性增加,以及基于差异染色方法鉴定出凋亡细胞群体增加,而非坏死细胞群体增加。我们确定了一份约40种炎症介质和热休克蛋白的清单,当PBMC暴露于rPA20或炭疽芽孢杆菌孢子/营养细胞时,它们的变化情况相似。

结论

本研究表明,PA20对人外周血白细胞有影响,并且在没有其他PA成分的情况下可诱导细胞凋亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/cf72c21eddf1/1471-2334-8-124-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/da56ee26f3d0/1471-2334-8-124-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/3b4521ed32c8/1471-2334-8-124-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/44000505d6c8/1471-2334-8-124-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/09dcb7c22b86/1471-2334-8-124-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/f66c6eae3875/1471-2334-8-124-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/71dd1c42dccf/1471-2334-8-124-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/ffd05dc78902/1471-2334-8-124-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/5caf865e63ec/1471-2334-8-124-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/fd4acfd39cea/1471-2334-8-124-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/65b56e3b404c/1471-2334-8-124-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/2d87f7795690/1471-2334-8-124-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/cf72c21eddf1/1471-2334-8-124-12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/da56ee26f3d0/1471-2334-8-124-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/3b4521ed32c8/1471-2334-8-124-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/44000505d6c8/1471-2334-8-124-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/09dcb7c22b86/1471-2334-8-124-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/f66c6eae3875/1471-2334-8-124-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/71dd1c42dccf/1471-2334-8-124-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/ffd05dc78902/1471-2334-8-124-7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/5caf865e63ec/1471-2334-8-124-8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/fd4acfd39cea/1471-2334-8-124-9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/65b56e3b404c/1471-2334-8-124-10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/2d87f7795690/1471-2334-8-124-11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1540/2564935/cf72c21eddf1/1471-2334-8-124-12.jpg

相似文献

1
Activity of the Bacillus anthracis 20 kDa protective antigen component.炭疽芽孢杆菌20 kDa保护性抗原成分的活性
BMC Infect Dis. 2008 Sep 22;8:124. doi: 10.1186/1471-2334-8-124.
2
New aspects of the infection mechanisms of Bacillus anthracis.炭疽芽孢杆菌感染机制的新方面。
Ann Agric Environ Med. 2012;19(4):613-8.
3
Self-association of the transmembrane domain of an anthrax toxin receptor.炭疽毒素受体跨膜结构域的自我缔合。
J Mol Biol. 2006 Jun 30;360(1):145-56. doi: 10.1016/j.jmb.2006.04.072. Epub 2006 May 15.
4
Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.PA63和PA83均在炭疽保护性抗原混合七聚体内被内吞:一种克服弗林蛋白酶缺陷的推定机制。
Arch Biochem Biophys. 2006 Feb 1;446(1):52-9. doi: 10.1016/j.abb.2005.11.013. Epub 2005 Dec 7.
5
Constitutive expression of protective antigen gene of Bacillus anthracis in Escherichia coli.炭疽芽孢杆菌保护性抗原基因在大肠杆菌中的组成型表达。
Biochem Biophys Res Commun. 2001 May 4;283(2):308-15. doi: 10.1006/bbrc.2001.4777.
6
Bacillus anthracis: a multi-faceted role for anthrax lethal toxin in thwarting host immune defenses.炭疽芽孢杆菌:炭疽致死毒素在对抗宿主免疫防御中的多方面作用。
Int J Biochem Cell Biol. 2007;39(1):20-4. doi: 10.1016/j.biocel.2006.08.010. Epub 2006 Sep 1.
7
Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin.膜型-1基质金属蛋白酶(MT1-MMP)可保护恶性细胞免受经重新设计的炭疽致死毒素的杀肿瘤活性影响。
Int J Biochem Cell Biol. 2005 Jan;37(1):142-54. doi: 10.1016/j.biocel.2004.06.005.
8
Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.通过免疫捕获和同位素稀释质谱法准确、选择性地定量血浆中的炭疽保护性抗原。
Analyst. 2019 Mar 25;144(7):2264-2274. doi: 10.1039/c8an02479k.
9
Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.147位的缬氨酸-酪氨酸-酪氨酸-谷氨酸-异亮氨酸-甘氨酸-赖氨酸-153残基参与致死因子与炭疽芽孢杆菌保护性抗原的结合。
Biochem Biophys Res Commun. 2001 Jan 12;280(1):158-63. doi: 10.1006/bbrc.2000.4099.
10
The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.致死因子与炭疽保护性抗原(PA63)结合的肽抑制剂的结合构象:通过trNOESY核磁共振和分子模拟确定。
J Med Chem. 2004 Oct 21;47(22):5347-55. doi: 10.1021/jm040139a.

引用本文的文献

1
Recombinant full-length protective antigen and its 63 kDa form elicits protective response in formulation with addavax.与 Addavax 联合使用时,重组全长保护性抗原及其 63 kDa 形式可引发保护性应答。
Front Immunol. 2023 Jan 12;13:1075662. doi: 10.3389/fimmu.2022.1075662. eCollection 2022.
2
Involvement of Bacterial Extracellular Membrane Nanovesicles in Infectious Diseases and Their Application in Medicine.细菌细胞外膜纳米囊泡在传染病中的作用及其在医学中的应用。
Pharmaceutics. 2022 Nov 25;14(12):2597. doi: 10.3390/pharmaceutics14122597.
3
Anthrax toxin component, Protective Antigen, protects insects from bacterial infections.

本文引用的文献

1
Lethal factor of anthrax toxin binds monomeric form of protective antigen.炭疽毒素的致死因子与保护性抗原的单体形式结合。
Biochem Biophys Res Commun. 2007 Aug 31;360(3):690-5. doi: 10.1016/j.bbrc.2007.06.124. Epub 2007 Jul 3.
2
GeneCite: a stand-alone open source tool for high-throughput literature and pathway mining.GeneCite:一款用于高通量文献和通路挖掘的独立开源工具。
OMICS. 2007 Summer;11(2):143-51. doi: 10.1089/omi.2007.4322.
3
Interaction of the 20 kDa and 63 kDa fragments of anthrax protective antigen: kinetics and thermodynamics.
炭疽毒素成分,保护性抗原,可保护昆虫免受细菌感染。
PLoS Pathog. 2020 Aug 31;16(8):e1008836. doi: 10.1371/journal.ppat.1008836. eCollection 2020 Aug.
4
Accurate and selective quantification of anthrax protective antigen in plasma by immunocapture and isotope dilution mass spectrometry.通过免疫捕获和同位素稀释质谱法准确、选择性地定量血浆中的炭疽保护性抗原。
Analyst. 2019 Mar 25;144(7):2264-2274. doi: 10.1039/c8an02479k.
5
Constructing and transient expression of a gene cassette containing edible vaccine elements and shigellosis, anthrax and cholera recombinant antigens in tomato.构建包含食用疫苗元件以及志贺氏菌病、炭疽和霍乱重组抗原的基因盒并在番茄中进行瞬时表达。
Mol Biol Rep. 2018 Dec;45(6):2237-2246. doi: 10.1007/s11033-018-4385-3. Epub 2018 Sep 22.
6
Serum-Mediated Cleavage of Protective Antigen Is a Two-Step Process That Involves a Serum Carboxypeptidase.血清介导的保护性抗原裂解是一个两步过程,涉及血清羧肽酶。
mSphere. 2018 Jun 27;3(3). doi: 10.1128/mSphere.00091-18.
7
An anthrax subunit vaccine candidate based on protective regions of Bacillus anthracis protective antigen and lethal factor.一种基于炭疽芽孢杆菌保护性抗原和致死因子保护性区域的炭疽亚单位疫苗候选物。
Vaccine. 2010 Sep 24;28(41):6740-8. doi: 10.1016/j.vaccine.2010.07.075. Epub 2010 Aug 4.
8
Estrogen receptor-dependent genomic expression profiles in breast cancer cells in response to fatty acids.乳腺癌细胞中雌激素受体依赖性基因组表达谱对脂肪酸的响应。
J Carcinog. 2010 Feb 4;8:17. doi: 10.4103/1477-3163.59539.
9
Membrane translocation by anthrax toxin.炭疽毒素的膜转位。
Mol Aspects Med. 2009 Dec;30(6):413-22. doi: 10.1016/j.mam.2009.06.003. Epub 2009 Jun 27.
Biochemistry. 2005 Jan 25;44(3):1047-53. doi: 10.1021/bi047791s.
4
Cytokine response to infection with Bacillus anthracis spores.细胞因子对炭疽芽孢杆菌孢子感染的反应。
Infect Immun. 2004 Nov;72(11):6382-9. doi: 10.1128/IAI.72.11.6382-6389.2004.
5
The PA14 domain, a conserved all-beta domain in bacterial toxins, enzymes, adhesins and signaling molecules.PA14结构域,是细菌毒素、酶、黏附素和信号分子中一个保守的全β结构域。
Trends Biochem Sci. 2004 Jul;29(7):335-9. doi: 10.1016/j.tibs.2004.05.002.
6
Lethal factor of Bacillus anthracis cleaves the N-terminus of MAPKKs: analysis of the intracellular consequences in macrophages.
Int J Med Microbiol. 2000 Oct;290(4-5):421-7. doi: 10.1016/S1438-4221(00)80056-9.
7
Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.丝裂原活化蛋白激酶激酶家族成员对炭疽致死因子蛋白水解作用的敏感性。
Biochem J. 2000 Dec 15;352 Pt 3(Pt 3):739-45.
8
Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNgamma-induced release of NO and TNFalpha.炭疽致死因子可裂解巨噬细胞中的MKK3,并抑制脂多糖/γ干扰素诱导的一氧化氮和肿瘤坏死因子α的释放。
FEBS Lett. 1999 Nov 26;462(1-2):199-204. doi: 10.1016/s0014-5793(99)01502-1.
9
CD38 triggers cytotoxic responses in activated human natural killer cells.CD38在活化的人类自然杀伤细胞中触发细胞毒性反应。
Blood. 1999 Dec 1;94(11):3864-71.
10
The expression of the protective antigen of Bacillus anthracis in Bacillus subtilis.
J Appl Microbiol. 1998 May;84(5):741-6. doi: 10.1046/j.1365-2672.1998.00405.x.